We are live on ! Find out more
RPTP

RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP

Delisted

RPTP was delisted on the 24th of October, 2016.

Back to rankings

111 hedge funds and large institutions have $468M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more capital invested

Capital invested by funds: $252M → $468M (+$215M)

80% more call options, than puts

Call options by funds: $17.6M | Put options by funds: $9.77M

62% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 29

19% more funds holding

Funds holding: 93 → 111 (+18)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

75% less funds holding in top 10

Funds holding in top 10: 4 → 1 (-3)

Holders
111
Holders Change
+18
Holders Change %
+19.35%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.03%
New
47
Increased
26
Reduced
26
Closed
29
Calls
$17.6M
Puts
$9.77M
Net Calls
+$7.86M
Net Calls Change
+$7.28M

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$28.9M
2
MF
Magnetar Financial
Illinois
+$28.2M
3
AAM
Alpine Associates Management
Florida
+$27.1M
4
WIC
Water Island Capital
New York
+$23.9M
5
GLAM
Gardner Lewis Asset Management
Pennsylvania
+$13.8M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$41.1M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$24M
3
Goldman Sachs
Goldman Sachs
New York
-$16.8M
4
SCM
Sarissa Capital Management
Connecticut
-$15.4M
5
UBS AM
UBS AM
Illinois
-$8.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
101
Creative Planning
Kansas
$45K – – –
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
$31K +$6.55K +921 +36%
AIM
103
Acrospire Investment Management
Illinois
$31K +$24.5K +3,451 New
JG
104
Jefferies Group
New York
$27K +$21.3K +3,000 New
BJ
105
BlackRock Japan
Japan
$25K +$20K +2,811 New
UBS Group
106
UBS Group
Switzerland
$19K -$789K -110,918 -98%
TRCT
107
Tower Research Capital (TRC)
New York
$4K +$3.18K +447 New
TCIM
108
TIAA CREF Investment Management
New York
$2.55K +$108K +15,242 +6%
GT
109
Glenmede Trust
Pennsylvania
$1K +$1K +141 New
VOYA Investment Management
110
VOYA Investment Management
Georgia
$345 – – –
Fidelity Investments
111
Fidelity Investments
Massachusetts
– -$24M -4,463,302 Closed
SCM
112
Sarissa Capital Management
Connecticut
– -$15.4M -2,875,000 Closed
Millennium Management
113
Millennium Management
New York
– -$7.32M -1,362,118 Closed
HM
114
HealthCor Management
New York
– -$5.65M -1,051,315 Closed
GPP
115
Great Point Partners
Connecticut
– -$5.25M -978,350 Closed
GTC
116
Ghost Tree Capital
New York
– -$3.22M -600,000 Closed
Balyasny Asset Management
117
Balyasny Asset Management
Illinois
– -$1.82M -338,620 Closed
GC
118
Globeflex Capital
California
– -$1.14M -212,739 Closed
Susquehanna International Group
119
Susquehanna International Group
Pennsylvania
– -$1.49M -209,309 Closed
ACP
120
Acuta Capital Partners
California
– -$938K -174,708 Closed
Jacobs Levy Equity Management
121
Jacobs Levy Equity Management
New Jersey
– -$901K -167,700 Closed
TC
122
TFS Capital
Pennsylvania
– -$727K -135,382 Closed
Ameriprise
123
Ameriprise
Minnesota
– -$676K -125,860 Closed
QSS
124
Quantitative Systematic Strategies
Florida
– -$495K -92,474 Closed
UOC
125
UBS O'Connor
Illinois
– -$403K -75,000 Closed
2 3 4
5
6

RPTP Hedge Fund Activity: Q3 2016 in Review

111 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q3 2016, worth a combined $468M — up 85% from $252M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new RPTP positions and 29 closed out — a net gain of 18 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $28.9M. The largest seller was Broadfin Capital, cutting an estimated $41.1M.

  • 111 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q3 2016, up from 93 in Q2 2016.
  • Funds reported $468M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q3 2016, up 85% quarter-over-quarter.
  • 47 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q3 2016 and 29 closed out, a net change of +18 holders.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q3 2016 was AQR Arbitrage, an estimated $28.9M added.
  • The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q3 2016 was Broadfin Capital, an estimated $41.1M sold.

Based on aggregated 13F filings for Q3 2016.